封面
市場調查報告書
商品編碼
2077549

全球患者生成健康數據市場:按數據類型、最終用戶和地區分類

Global Patient Generated Health Data Market, By Data Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球患者生成健康數據市場預計到 2026 年將達到 102.4 億美元,預計到 2033 年將達到 343.9 億美元。預計從 2026 年到 2033 年,該市場將以 18.9% 的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 102.4億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 18.90% 2033年市場規模預測: 343.9億美元

患者產生的健康資料是指由患者自行建立、記錄或收集的健康資訊。隨著數位健康工具和技術的普及,患者擴大追蹤關鍵健康指標,例如活動量、睡眠、營養和生命徵象。這些數據在改善臨床療效、促進研究和最佳化醫療服務模式方面具有巨大潛力。與醫療服務提供者共用這些數據,有助於更深入了解患者的個別病情、治療反應以及生活方式因素隨時間的變化。然而,要有效利用這些數據,必須解決隱私和安全的挑戰,以建立病人的信任。此外,資料收集和評估方法的標準化對於從這個不斷發展的資料來源中挖掘最大價值至關重要。

市場動態:

全球患者生成健康數據市場的主要驅動力是數位健康工具的日益普及以及對患者參與和以患者為中心的護理模式的日益重視。穿戴式裝置和健康應用程式的廣泛使用促進了自我追蹤,從而擴大了患者數據量。有關數據共用和技術整合的有利法規進一步推動了市場成長。然而,對資料隱私的擔憂、缺乏標準以及無法利用原始資料等問題目前限制市場成長。巨量資料評估分析解決方案的開發帶來了盈利的機會。此外,消費者醫療保健技術與電子健康記錄 (EHR) 系統的整合預計將在未來幾年加速市場收入成長。

本研究的主要特點:

  • 這項研究揭示了各個細分市場的潛在成長機會,並為該市場說明了一個有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數,介紹了全球患者生成健康數據市場中主要公司的概況。
  • 本次調查涵蓋的主要公司包括 Apple Inc.、Fitbit, Inc.、Dexcom, Inc.、Medtronic plc、Omada Health, Inc.、Propeller Health、AliveCor, Inc.、WellDoc, Inc.、Noom, Inc.、Livongo Health、HealthMine, Inc.、Epic Systems Corporation、Allscripts Solutions、Ceralner Corporation, .
  • 本報告提供的見解將有助於各公司的行銷負責人和經營團隊就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份「全球患者生成健康數據市場」報告的目標受群眾外包括行業內的各類相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用分析全球患者生成健康數據市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 全球病患產生健康資料市場:依資料類型分類,2021-2033年

  • 健身和健康數據
  • 疾病管理數據
  • 遠端監控數據
  • 其他

第5章 全球病患產生健康資料市場:依最終使用者分類,2021-2033年

  • 醫院和診所
  • 研究中心
  • 醫療保健支付方
  • 其他

第6章 全球病患產生健康資料市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第7章 競爭情勢

  • Apple Inc.
  • Fitbit, Inc.
  • Dexcom, Inc.
  • Medtronic plc
  • Omada Health, Inc.
  • Propeller Health
  • AliveCor Inc.
  • WellDoc, Inc.
  • Noom, Inc.
  • Livongo Health
  • HealthMine, Inc.
  • Epic Systems Corporation
  • Allscripts Healthcare Solutions
  • Cerner Corporation
  • Athenahealth, Inc.

第8章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6567

Global Patient Generated Health Data Market is estimated to be valued at USD 10.24 Bn in 2026 and is expected to reach USD 34.39 Bn by 2033, growing at a compound annual growth rate (CAGR) of 18.9% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 10.24 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 18.90% 2033 Value Projection: USD 34.39 Bn

Patient generated health data refers to health information created, recorded, or gathered by or from patients. With the rise of digital health tools and technologies, patients are increasingly self-tracking vital health indicators like activity, sleep, nutrition, vital signs, and more. This data holds immense potential for improving clinical outcomes, research, and healthcare delivery models. When shared with providers, it can help gain deeper insights into an individual's conditions, treatment response, and lifestyle factors over time. However, utilizing this data requires addressing privacy and security challenges to build patient trust. Standardization of data collection and evaluation methods is also critical for deriving maximum value from this evolving data source.

Market Dynamics:

The global patient generated health data market is primarily driven by the growing adoption of digital health tools along with increasing emphasis on patient engagement and centric care models. The wide proliferation of wearable devices and health apps that facilitate self-tracking is expanding the volume of patient data. Favorable regulations around data sharing and technology integration are further promoting market growth. However, data privacy concerns, a lack of standards, and the inability to leverage raw data currently restrain the market. The development of analytics solutions for big data evaluation presents lucrative opportunities. Integration of consumer health technologies with EHR (Electronic Health Record) systems could also accelerate market revenues over the coming years.

Key Features of the Study:

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global patient generated health data market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Apple Inc., Fitbit, Inc., Dexcom, Inc., Medtronic plc, Omada Health, Inc., Propeller Health, AliveCor, Inc., WellDoc, Inc., Noom, Inc., Livongo Health, HealthMine, Inc., Epic Systems Corporation, Allscripts Healthcare Solutions, Cerner Corporation and Athenahealth, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global patient generated health data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global patient generated health data market

Detailed Segmentation:

  • By Data Type (Revenue, USD Bn, 2021 - 2033)
  • Fitness & wellness data
  • Disease management data
  • Remote monitoring data
  • Others
  • By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals & clinics
  • Research centers
  • Healthcare payers
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles:
  • Apple Inc.
  • Fitbit, Inc.
  • Dexcom, Inc.
  • Medtronic plc
  • Omada Health, Inc.
  • Propeller Health
  • AliveCor, Inc.
  • WellDoc, Inc.
  • Noom, Inc.
  • Livongo Health
  • HealthMine, Inc.
  • Epic Systems Corporation
  • Allscripts Healthcare Solutions
  • Cerner Corporation
  • Athenahealth, Inc.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Patient Generated Health Data Market, By Data Type
    • Global Patient Generated Health Data Market, By End User
    • Global Patient Generated Health Data Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Patient Generated Health Data Market, By Data Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Fitness & wellness data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Disease management data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Remote monitoring data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

5. Global Patient Generated Health Data Market, By End User, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals & clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Research centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Healthcare payers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Patient Generated Health Data Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Data Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Data Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Data Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • China
      • Japan
      • India
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Data Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Data Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Data Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Apple Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fitbit, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dexcom, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Omada Health, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Propeller Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AliveCor Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • WellDoc, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Noom, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Livongo Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HealthMine, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Epic Systems Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Allscripts Healthcare Solutions
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cerner Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Athenahealth, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Section

  • Research Methodology
  • About us